The roles of dipeptidyl peptidase-4 and its inhibitors in the regulation of airway epithelial-mesenchymal transition

References

• Durinx C, Lambeir AM, Bosmans E, et al. Molecular characterization of dipeptidyl peptidase activity in serum: soluble CD26/dipeptidyl peptidase IV is responsible for the release of X‐Pro dipeptides. Eur J Biochem. 2000; 267(17):5608–5613. doi:10.1046/j.1432-1327.2000.01634.x.
   PubMedGoogle Scholar
• Gorrell MD. Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders. Clin Sci. 2005; 108(4):277–292. doi:10.1042/CS20040302.
   PubMed Web of Science ®Google Scholar
• Pitman MR, Sulda ML, Kuss B, et al. Dipeptidyl peptidase 8 and 9—guilty by association. Front Biosci. 2009; 14:3619–3633. doi:10.2741/3476.
   PubMed Web of Science ®Google Scholar
• Heike M, Mobius U, Knuth A, Meuer S, Meyer Zum Buschenfelde KH. Tissue distribution of the T cell activation antigen Ta1. Serological, immunohistochemical and biochemical investigations. Clin Exp Immunol. 1988; 74:431–434.
   PubMed Web of Science ®Google Scholar
• Dinjens WN, ten Kate J, Wijnen JT, et al. Distribution of adenosine deaminase-complexing protein in murine tissues. J Biol Chem. 1989;264(32):19215–19220.
   PubMed Web of Science ®Google Scholar
• Mentzel S, Dijkman HB, Van Son JP, Koene RA, Assmann KJ. Organ distribution of aminopeptidase A and dipeptidyl peptidase IV in normal mice. J Histochem Cytochem. 1996;44(5):445–461. doi:10.1177/44.5.8627002.
   PubMed Web of Science ®Google Scholar
• Colice G, Price D, Gerhardsson de Verdier M, et al. The effect of DPP-4 inhibitors on asthma control: an administrative database study to evaluate a potential pathophysiological relationship. POR. 2017; 8:231–240. doi:10.2147/POR.S144018.
   Google Scholar
• Mentlein R. Dipeptidyl-peptidase IV (CD26) – role in the inactivation of regulatory peptides. Regul Pept. 1999;85(1):9–24. doi:10.1016/S0167-0115(99)00089-0.
   PubMed Web of Science ®Google Scholar
• Casrouge A, Sauer AV, Barreira da Silva R, et al. Lymphocytes are a major source of circulating soluble dipeptidyl peptidase 4. Clin Exp Immunol. 2018; 194(2):166–179. doi:10.1111/cei.13163.
   PubMed Web of Science ®Google Scholar
• Emson C, Pham T-H, Manetz S, et al. Periostin and dipeptidyl peptidase-4: potential biomarkers of interleukin 13 pathway activation in asthma and allergy. Immunol Allergy Clinics. 2018; 38 (4):611–628. doi:10.1016/j.iac.2018.06.004.
   PubMed Web of Science ®Google Scholar
• Deacon CF, Hughes TE, Holst JJ. Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide 1 in the anesthetized pig. Diabetes. 1998; 47(5):764–769. doi:10.2337/diabetes.47.5.764.
   PubMed Web of Science ®Google Scholar
• Yazbeck R, Howarth GS, Abbott CA. Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease? Trends Pharmacol Sci. 2009;30(11):600–607. doi:10.1016/j.tips.2009.08.003.
   PubMed Web of Science ®Google Scholar
• Pacheco R, Martinez-Navio JM, Lejeune M, et al. CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse. Proc Natl Acad Sci USA. 2005;102(27):9583–9588. doi:10.1073/pnas.0501050102.
   PubMed Web of Science ®Google Scholar
• Miyoshi T, Nakamura K, Yoshida M, et al. Effect of vildagliptin, a dipeptidyl peptidase 4 inhibitor, on cardiac hypertrophy induced by chronic beta-adrenergic stimulation in rats. Cardiovasc Diabetol. 2014;13(1):43. doi:10.1186/1475-2840-13-43.
   PubMed Web of Science ®Google Scholar
• Lambrecht BN, Hammad H. The immunology of asthma. Nat Immunol. 2015; 16(1):45–56. doi:10.1038/ni.3049.
   PubMed Web of Science ®Google Scholar
• Fahy JV. Type 2 inflammation in asthma—present in most, absent in many. Nat Rev Immunol. 2015;15(1):57–65. doi:10.1038/nri3786.
   PubMed Web of Science ®Google Scholar
• Nieto-Fontarigo JJ, González-Barcala FJ, San-José ME, et al. Expansion of a CD26low effector TH subset and reduction in circulating levels of sCD26 in stable allergic asthma in adults. J Investig Allergol Clin Immunol. 2018;28(2):113–125. doi:10.18176/jiaci.0224.
   PubMed Web of Science ®Google Scholar
• Ta NN, Li Y, Schuyler CA, et al. DPP-4 (CD26) inhibitor alogliptin inhibits TLR4-mediated ERK activation and ERK-dependent MMP-1 expression by U937 histiocytes[J]. Atherosclerosis. 2010; 213(2):429–435. doi:10.1042/CS20040302.
   PubMed Web of Science ®Google Scholar
• O’Leary HA, Capitano M, Cooper S, et al. DPP4 truncated GM-CSF and IL-3 manifest distinct receptor-binding and regulatory functions compared with their full-length forms. Leukemia. 2017;31(11):2468–2478. doi:10.1038/leu.2017.98.
   PubMed Web of Science ®Google Scholar
• Stephan M, Suhling H, Schade J, et al. Effects of dipeptidyl peptidase‐4 inhibition in an animal model of experimental asthma: a matter of dose, route, and time. Physiol Rep. 2013;1(5):e00095. doi:10.1002/phy2.95.
   PubMedGoogle Scholar
• Tasic T, Bäumer W, Schmiedl A, et al. Dipeptidyl peptidase IV (DPP4) deficiency increases Th1‐driven allergic contact dermatitis. Clin Exp Allergy. 2011;41 (8):1098–1107. doi:10.1111/j.1365-2222.2011.03778.x.
   PubMed Web of Science ®Google Scholar
• Yan S, Geßner R, Dietel C, et al. Enhanced ovalbumin‐induced airway inflammation in CD26−/− mice. Eur J Immunol. 2012; 42 (2):533–540. doi:10.1002/eji.201041038.
   PubMed Web of Science ®Google Scholar
• Bengsch B, Seigel B, Flecken T, Wolanski J, Blum HE, Thimme R. Human Th17 cells express high levels of enzymatically active dipeptidylpeptidase IV(CD26). JI. 2012; 188(11):5438–5447. doi:10.4049/jimmunol.1103801.
   Web of Science ®Google Scholar
• Salgado FJ, Pérez-Díaz A, Villanueva NM, Lamas O, Arias P, Nogueira M. CD26: a negative selection marker for human Treg cells. Cytometry. 2012;81A(10):843–855. doi:10.1002/cyto.a.22117.
   Google Scholar
• Bergeron C, Tulic MK, Hamid Q. Airway remodelling in asthma: from benchside to clinical practice. Can Respir J. 2010; 17(4):e85–93. doi:10.1155/2010/318029.
   PubMed Web of Science ®Google Scholar
• Bai TR. Evidence for airway remodeling in chronic asthma. Curr Opin Allergy Clin Immunol. 2010;10(1):82–86. doi:10.1097/ACI.0b013e32833363b2.
   PubMed Web of Science ®Google Scholar
• Ricciardolo FLM, Sorbello V, Folino A, et al. Identification of IL-17F/frequent exacerbator endotype in asthma. J Allergy Clin Immunol. 2017;140(2):395–406. doi:10.1016/j.jaci.2016.10.034.
   PubMed Web of Science ®Google Scholar
• Lettau M, Dietz M, Vollmers S, et al. Degranulation of human cytotoxic lymphocytes is a major source of proteolytically active soluble CD26/DPP4. Cell Mol Life Sci. 2020; 77(4):751–764. doi:10.1007/s00018-019-03207-0.
   PubMed Web of Science ®Google Scholar
• Lun SWM, Wong CK, Ko FWS, et al. Increased expression of plasma and CD4+ T lymphocyte costimulatory molecule CD26 in adult patients with allergic asthma. J Clin Immunol. 2007; 27(4):430–437. doi:10.1007/s10875-007-9093-z.
   PubMed Web of Science ®Google Scholar
• Schade J, Schmiedl A, Kehlen A, et al. Airway‐specific recruitment of T cells is reduced in a CD26‐deficient F344 rat substrain. Clin Exp Immunol. 2009; 158 (1):133–142. doi:10.1111/j.1365-2249.2009.03991.x.
   PubMed Web of Science ®Google Scholar
• Matsuno O, Miyazaki E, Nureki S, et al. Soluble CD26 is inversely associated with disease severity in patients with chronic eosinophilic pneumonia. Biomark Insights. 2006;1:1–4. doi:10.1177/27190600100012.
   Google Scholar
• Remes ST, Delezuch W, Pulkki K, et al. Association of serum‐soluble CD26 and CD30 levels with asthma, lung function and bronchial hyper‐responsiveness at school age. Acta Paediatrica. 2011; 100 (9):e106–e111. doi:10.1111/j.1651-2227.2011.02264.x.
   PubMed Web of Science ®Google Scholar
• Hollande C, Boussier J, Ziai J, et al. Inhibition of the dipeptidyl peptidase DPP4 (CD26) reveals IL-33-dependent eosinophil-mediated control of tumor growth. Nat Immunol. 2019; 20 (3):257–264. doi:10.1038/s41590-019-0321-5.
   PubMed Web of Science ®Google Scholar
• Gong S, Li J, Ma L, et al. Blockade of dopamine D1‐like receptor signalling protects mice against OVA‐induced acute asthma by inhibiting B‐cell activating transcription factor signalling and Th17 function. FEBS J. 2013; 280(23):6262–6273. doi:10.1111/febs.12549.
   PubMed Web of Science ®Google Scholar
• Zhang L, Li K, Bing Ma L, et al. Effects and mechanism of arsenic trioxide on reversing the asthma pathologies including Th17-IL-17 axis in a mouse model. Iran J Allergy Asthma Immunol. 2012; 11(2):133–145. doi:011.02/ijaai.133145.
   PubMed Web of Science ®Google Scholar
• Shiobara T, Chibana K, Watanabe T, et al. Dipeptidyl peptidase-4 is highly expressed in bronchial epithelial cells of untreated asthma and it increases cell proliferation along with fibronectin production in airway constitutive cells. Respir Res. 2016;17(1):28. doi:10.1186/s12931-016-0342-7.
   PubMed Web of Science ®Google Scholar